Should You Invest in the iShares Biotechnology ETF (IBB)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB) , a passively managed exchange traded fund launched on February 5, 2001. An increasingly popular option among retail and institutional investors, passively managed ETFs offer low costs, transparency, flexibility, and tax efficiency; they are also excellent vehicles for long term investors. Even though ETFs offer diversified exposure that minimizes single stock risk, in ...